Nucor Corp

NUE remains in a structural uptrend with a recent Bullish Pivot Point signaling further mean-reversion strength. Medium-term directional bias is bullish, underpinned by rising EMAs and Stage 2 advance dynamics. Short-term price action is consolidating around the 9/20 EMA zone, suggesting patient accumulation on pullbacks. For the Growth at Reasonable Price strategy, waiting for a constructive retracement into the short-term EMA band or the 50-day SMA offers a favorable entry opportunity.

• ↑Q2 revenue of $10.4B (+23% YoY) and net income $1.16B ($5.04/share) surpassed forecasts
• ↑Record 7.1M tons shipments and 18% QoQ backlog growth signal sustained demand
• ↓Negative profitability factors and lagging price adjustments may compress margins in Q3